Zobrazeno 1 - 10
of 49
pro vyhledávání: '"SCCA-IgM"'
Autor:
Silvia Bettini, Emanuel Bordigato, Gabriella Milan, Chiara Dal Pra’, Francesca Favaretto, Anna Belligoli, Marta Sanna, Roberto Serra, Mirto Foletto, Luca Prevedello, Luca Busetto, Giorgio Fassina, Roberto Vettor, Roberto Fabris
Publikováno v:
Obesity Facts, Vol 12, Iss 3, Pp 291-306 (2019)
Background: Non-alcoholic fatty liver disease (NAFLD) has a high prevalence in obesity and its presence should be screened. Laparoscopic sleeve gastrectomy (LSG) is an effective treatment for obesity, but its effects on NAFLD are still to be firmly e
Externí odkaz:
https://doaj.org/article/3aff2ea869144bbfbed746af1f4e66af
Autor:
Ali LH, Higazi AM, Moness HM, Farag NM, Saad ZM, Moukareb HA, Soliman W, El Sagheer G, Abd El Hamid SR, Abdl Hamid H
Publikováno v:
Clinical and Experimental Gastroenterology, Vol Volume 12, Pp 51-66 (2019)
Lamia H Ali,1,* Aliaa M Higazi,1,* Hend M Moness,1 Naglaa M Farag,1 Zienab M Saad,2 Hamdy A Moukareb,2 Wael Soliman,2 Ghada El Sagheer,3 Sahar R Abd El Hamid,4 Haytham Abdl Hamid2 1Department of Clinical and Chemical Pathology, Faculty of Medicine, M
Externí odkaz:
https://doaj.org/article/5ecac96e05a04728bea9c59549cd6623
Autor:
F. Soldà, B. Penzo, A. Imondi, Fabio Farinati, A. Sammarco, Umberto Cillo, Alessandro Vitale, Filippo Pelizzaro, Camillo Aliberti, A. Sartori, Romilda Cardin
Aim: Squamous cell carcinoma antigen immune complexed with immunoglobulin M (SCCA-IgM) is a useful but not completely satisfactory biomarker of hepatocellular carcinoma (HCC). Considering its gender-specific behavior in preclinical models, we investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590d0308c40e6624c94726bfc80c045d
http://hdl.handle.net/11577/3350930
http://hdl.handle.net/11577/3350930
Autor:
Chiara Dal Pra, Emanuel Bordigato, Giorgio Fassina, Roberto Vettor, Silvia Bettini, Gabriella Milan, Roberto Fabris, Francesca Favaretto, Luca Prevedello, Roberto M. Serra, Luca Busetto, Mirto Foletto, Marta Sanna, Anna Belligoli
Publikováno v:
Obesity Facts, Vol 12, Iss 3, Pp 291-306 (2019)
Background: Non-alcoholic fatty liver disease (NAFLD) has a high prevalence in obesity and its presence should be screened. Laparoscopic sleeve gastrectomy (LSG) is an effective treatment for obesity, but its effects on NAFLD are still to be firmly e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448e9985f61c3c5a2ae8df9371d93839
http://hdl.handle.net/11577/3303217
http://hdl.handle.net/11577/3303217
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hoang Bui Huu, Claudio Tiribelli, Thuy Do Thi Thanh, Andrea Gallotta, Hoa Pham Thi Le, Nhuong Ha Thuc, Giorgio Fassina, Patrizia Pontisso, Laura Paneghetti, An Luong Bac
Publikováno v:
Scandinavian journal of clinical and laboratory investigation. 78(3)
Viral hepatitis infection is a major global issue and a leading cause of liver disease and associated deaths. Over time, patients infected with hepatitis B (HBV) or C virus (HCV) develop cirrhosis and, eventually, hepatocellular carcinoma (HCC). For
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb2e68608b007955e4bc573da4666a6a
https://pubmed.ncbi.nlm.nih.gov/29381084
https://pubmed.ncbi.nlm.nih.gov/29381084
Autor:
Andrea Gallotta, A. Martini, Adriána Bednárová, Patrizia Pontisso, Viera Mrázová, Dáša Kružlicová, Vladimir Frecer, Alessandra Biasiolo, Stanislav Miertus, Giorgio Fassina, Laura Paneghetti
Non-alcoholic steato-hepatitis (NASH) is a severe disease characterised by liver inflammation and progressive hepatic fibrosis, which may progress to cirrhosis and hepatocellular carcinoma. Clinical evidence suggests that in hepatitis C virus patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cce552c9cf60ff1ca9f429cbebb0156
http://hdl.handle.net/11577/3270013
http://hdl.handle.net/11577/3270013
Autor:
M.R. Buonocore, D. Donnini, Silvia Fargion, Catia Pilon, S. Maier, Claudio Pagano, L.A. Sechi, Luca Valenti, S.L. Crocè, Giorgio Soardo, Roberto Vettor
Background: NAFLD (non-alcoholic fatty liver disease) and NASH (non-alcoholic steatohepatitis) are emerging conditions that sequentially affect hepatocyte metabolism. Fibroblast Growth Factor 21 (FGF21) is produced by the liver and has autocrine and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0d1e799dad34e4c6828d13f595dc18c
http://hdl.handle.net/11368/2935699
http://hdl.handle.net/11368/2935699
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.